Stay updated with breaking news from Belgium Fixed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging progress in multiplex shRNA platform development, which allows now targeting of up to four genes simultaneously, were...
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging...
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement...
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News:Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today a...
17.03.2023 - MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) - Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor ... Seite 1